These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10214975)

  • 1. Sodium nitroprusside inhibits the tyrosine hydroxylase activity of the median eminence in the rat.
    González MC; Llorente E; Abreu P
    Neurosci Lett; 1998 Oct; 254(3):133-6. PubMed ID: 10214975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide inhibits tyrosine hydroxylase of rat median eminence.
    Abreu P; Llorente E; Sánchez JJ; González MC
    Life Sci; 2000 Sep; 67(16):1941-6. PubMed ID: 11072870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 beta stimulates tyrosine hydroxylase activity in the median eminence.
    Abreu P; Llorente E; Hernández MM; González MC
    Neuroreport; 1994 Jun; 5(11):1356-8. PubMed ID: 7919198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue inhibits stimulatory effect of sodium nitroprusside but not of 3-morpholino sydnonimine on prolactin secretion in freely moving male rats.
    González MC; Llorente E
    Brain Res Bull; 1998 Jun; 46(3):229-31. PubMed ID: 9667816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.
    Arbogast LA; Soares MJ; Tomogane H; Voogt JL
    Endocrinology; 1992 Jul; 131(1):105-13. PubMed ID: 1351837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin in cerebrospinal fluid: a probable site of prolactin autoregulation.
    Nicholson G; Greeley GH; Humm J; Youngblood WW; Kizer JS
    Brain Res; 1980 May; 190(2):447-57. PubMed ID: 6102886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged pertussis toxin treatment affects morphine's action on tuberoinfundibular dopaminergic neuron activity and on prolactin secretion.
    Lin JY; Pan JT
    Brain Res; 1996 Jul; 727(1-2):182-6. PubMed ID: 8842396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for protein kinase C involvement in the short-term activation by prolactin of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons.
    Pasqualini C; Guibert B; Frain O; Leviel V
    J Neurochem; 1994 Mar; 62(3):967-77. PubMed ID: 7906722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass and activity of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons of the aged brain. Control by prolactin and ovarian hormones.
    Gonzalez HA; Kedzierski W; Porter JC
    Neuroendocrinology; 1988 Dec; 48(6):663-7. PubMed ID: 2907999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
    Huang SK; Pan JT
    Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitric oxide donors sodium nitroprusside and 3-morpholino-sydnonimine on prolactin secretion in conscious rats.
    Gonzalez MC; Linares JD; Santos M; Llorente E
    Neurosci Lett; 1996 Jan; 203(3):167-70. PubMed ID: 8742019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone decreases tyrosine hydroxylase phosphorylation state and increases protein phosphatase 2A activity in the stalk-median eminence on proestrous afternoon.
    Liu B; Arbogast LA
    J Endocrinol; 2010 Feb; 204(2):209-19. PubMed ID: 19945993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity.
    Arbogast LA; Voogt JL
    Brain Res; 1994 Aug; 655(1-2):17-24. PubMed ID: 7812770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of tuberoinfundibular and tuberohypophysial dopamine neurons following intracerebroventricular administration of bombesin.
    Manzanares J; Toney TW; Lookingland KJ; Moore KE
    Brain Res; 1991 Nov; 565(1):142-7. PubMed ID: 1773350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The different effects of i.c.v. injection of pituitary adenylate cyclase activating polypeptide (PACAP) on prolactin secretion in adult male and lactating rats.
    Tohei A; Ikeda M; Hokao R; Shinoda M
    Exp Anim; 2009 Oct; 58(5):489-95. PubMed ID: 19897932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist of pituitary adenylate cyclase activating polypeptide suppresses prolactin secretion without changing the activity of dopamine neurons in lactating rats.
    Tohei A; Matsuzaki M; Kogo H
    Neuroendocrinology; 2001 Jan; 73(1):68-74. PubMed ID: 11174019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of tyrosine hydroxylase in the median eminence: demonstration of a central role for the pituitary gland.
    Gonzalez HA; Kedzierski W; Aguila-Mansilla N; Porter JC
    Endocrinology; 1989 May; 124(5):2122-7. PubMed ID: 2565217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in tuberoinfundibular dopaminergic neuron activity during the rat estrous cycle in relation to the prolactin surge: alteration by a mammary carcinogen.
    Pasqualini C; Bojda F; Gaudoux F; Guibert B; Leviel V; Teissier E; Rips R; Kerdelhue B
    Neuroendocrinology; 1988 Sep; 48(3):320-7. PubMed ID: 2903462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.